home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024
Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024
Post navigation
Previous Post
Previous
Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024
Next Post
Next
IDRx Announces $120 Million Series B Financing to Advance Potential Best-in-class New Treatment for Gastrointestinal Stromal Tumor (GIST)